RAS Mutations Contribute to Evolution of Chronic Myelomonocytic Leukemia to the Proliferative Variant

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-09-2112
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

RAS Mutations and Clonality Analysis in Children With Juvenile Myelomonocytic Leukemia (JMML)

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1999English

Prognostic Interaction Between ASXL1 and TET2 Mutations in Chronic Myelomonocytic Leukemia

Blood Cancer Journal
OncologyHematology
2016English

Alteration in the Cytokine Secretion of Bone Marrow Stromal Cells From Patients With Chronic Myelomonocytic Leukemia Contribute to Impaired Hematopoietic Supportive Activity

Stem Cells International
Cell BiologyMolecular Biology
2018English

Chronic Myelomonocytic Leukemia in the Light of the WHO Proposals

Haematologica
Hematology
2007English

Heterogeneous Patterns of CEBP Mutation Status in the Progression of Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia to Acute Myelogenous Leukemia

Clinical Cancer Research
Cancer ResearchOncology
2005English

Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Interleukin 4 Suppresses the Spontaneous Growth of Chronic Myelomonocytic Leukemia Cells.

Journal of Clinical Investigation
Medicine
1991English

Chronic Myelomonocytic Leukemia: Current Classification, Diagnosis and Risk Stratification

Cancer therapy & Oncology International Journal
2017English

Erythroid Variant of Chronic Myelogenous Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy